BIOCARDIA BCDA 深 沪
已收盘 09-19 16:00:00 美东时间
2.98
-0.100
-3.25%
华盛通- 最 高3.25
- 今 开3.16
- 成交量 35.93万股
- 最 低 2.95
- 昨 收 3.08
- 总市值 542.45万
- 52周最高 23.25
- 市盈率 静 --
- 换手率 19.74%
- 52周最低 1.9562
- 委 比 -58.03%
- 总股本 182.03万
- 历史最高 129.00
- 量 比 0.97
- 振 幅 9.74%
- 历史最低 2.95
- 每 手 1
- 风险率 2.43%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多BioCardia regains compliance with Nasdaq Capital Market
BioCardia (NASDAQ:BCDA) said the company has regained full compliance with the Nasdaq Capital Market’s listing requirements. Press Release More on BioCardia BioCardia, Inc. (BCDA) Q2 2024 Earnings Cal...
09-18 20:35
Catalyst Watch: FOMC, FedEx earnings, Electronic Arts event, and triple witching day
Welcome to Seeking Alpha's Catalyst Watch - a breakdown of some of next week's actionable events that stand out. Check out Seeking Alpha's earnings calendar for a full list of companies due to report....
09-14 03:00
Peering Into BioCardia's Recent Short Interest
BioCardia's (NYSE:BCDA) short percent of float has risen 71.29% since its last ...
09-05 01:00
Ensysce Biosciences (ENSC) Stock Is Down 30% Today: What's Going On?
Ensysce Biosciences shares are trading lower by 30% during Thursday's session. The company announced a $5 million registered direct offering and concurrent private placement.
08-29 23:10
Why BioCardia (BCDA) Stock Is Up 95% Today
BioCardia shares are trading higher by 95% during Thursday's session. The FDA cleared the company to market its Morph DNA Steerable Introducer product family.
08-29 21:28
Market-Moving News for August 29th
BCDA: 162% | BioCardia shares are trading higher after FDA cleared the company to market its Morph DNA Steerable Introducer product family. LUCY: 72% | Innovative Eyewear shares are trading higher after
08-29 20:24
Analysts Offer Insights on Healthcare Companies: BioCardia (BCDA) and CytomX Therapeutics (CTMX)
Analysts have been eager to weigh in on the Healthcare sector with new ratings ...
08-22 21:20
快讯 | biocardia报告2024年第二季度业务亮点和财务结果
BioCardia Reports Second Quarter 2024 Business Highlights and Financial Results
08-14 04:30
BioCardia Q2 2024 GAAP EPS $(0.88), Sales $3.000K Miss $50.000K Estimate
BioCardia (NASDAQ:BCDA) reported quarterly losses of $(0.88) per share. The com...
08-14 04:05
BioCardia Says Submitted 510(K) For Approval Of Its Patented Morph DNA Steerable Introducer Sheath
This product family is intended to provide a pathway through which medical instruments, such as balloon dilatation catheters, guidewires, or other therapeutic devices, may be introduced into the peripheral vasculature or
07-30 19:09
